![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, May 10, 2018 11:08:32 AM
WATCH for possible breakout above 22.25
Target: 23.68
"In animal models, we can reproduce and demonstrate up to 10 times the potency of IVIg. If we can do this in humans, it will be a game-changer for the IVIg marketplace, which today is a global supply constrained market with over $4 billion in sales in autoimmune indications. IVIg in autoimmune indications is a very difficult therapy for patients often requiring infusions over one or more days with challenging side effects. A drug with a fraction of the volume and infusion time and with the potential to dose higher for better efficacy could create meaningful value for patients and our investors.
We believe a single trial with a dose-ranging in normal volunteers progressing directly to patients in a population such as ITP, where IVIg is approved, could be conceded quickly, allowing us to show the benefit of this innovative compound within two years and providing another catalyst for our stocks from our promising autoimmune portfolio.''
Here is were the money will be made with approval. Note the conceded quickly. All we have to know is the trials come through. We will be the only one in the field for a long time if we get approval. Not long to wait. I hope we have a new production facility for these drugs. CW sounded totally excited when talking about the above. A drug with no serious competition is what we want. From what I heard he almost started talking about a second drug for approval at the same time and then he went quiet. I hope we hear more on the next cc.
Any Copaxone sales just helps get us to that point in the mean time. The delay hurt us and I guess the production line gets a pass for letting that happen. We are on notice for the future where we produce our drugs.
Shorts positions fell to 3.5M as of the 30th.
Note the increased in institutional buying each quarter. Scarfing up the shares,
https://www.nasdaq.com/symbol/mnta/institutional-holdings Each quarter they keep adding. First quarter being reported now.
We keep racking up patents,
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=2&f=G&l=50&co1=AND&d=PG01&s1=momenta&OS=momenta&RS=momenta
As the little man says pointing his small finger at his chin, FOUR BILLION DOLLARS.
Boing X 2
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM